Stockscreener 앱 받기
15.05
1.12%
-0.17
시간 외 거래:
15.05
전일 마감가:
$15.22
열려 있는:
$15.22
하루 거래량:
102.52K
Relative Volume:
1.61
시가총액:
$310.75M
수익:
-
순이익/손실:
-
주가수익비율:
-0.5023
EPS:
-29.96
순현금흐름:
-
1주 성능:
+2.94%
1개월 성능:
+12.90%
6개월 성능:
+4.37%
1년 성능:
+1,095%
1일 변동 폭
$15.02
$15.41
1주일 범위
$14.14
$15.76
52주 변동 폭
$10.92
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
명칭
Shoulder Innovations Inc
전화
616-566-0286
주소
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS
Compare SI vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
15.05 | 314.26M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | BTIG Research | Buy |
| 2025-08-25 | 개시 | Goldman | Buy |
| 2025-08-25 | 개시 | Jefferies | Buy |
| 2025-08-25 | 개시 | Piper Sandler | Overweight |
| 2023-03-06 | 다운그레이드 | Compass Point | Neutral → Sell |
| 2023-03-06 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2023-03-02 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | 다운그레이드 | Compass Point | Buy → Neutral |
| 2023-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-03-01 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-01-06 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-01-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-12 | 재확인 | Wedbush | Outperform |
| 2022-12-05 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-10-26 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-06 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | 개시 | BTIG Research | Buy |
| 2022-06-13 | 개시 | Wells Fargo | Overweight |
| 2022-06-09 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-03-21 | 개시 | BofA Securities | Buy |
| 2022-01-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-12-16 | 개시 | B. Riley Securities | Buy |
| 2021-11-11 | 개시 | JP Morgan | Overweight |
| 2021-11-08 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | 개시 | Morgan Stanley | Overweight |
| 2021-06-14 | 개시 | Goldman | Neutral |
| 2021-01-14 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-12-22 | 개시 | Wedbush | Outperform |
| 2020-12-17 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | 개시 | Craig Hallum | Buy |
| 2020-10-16 | 개시 | Compass Point | Buy |
| 2020-03-16 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | 개시 | Barclays | Overweight |
| 2019-11-18 | 개시 | Compass Point | Buy |
모두보기
Shoulder Innovations Inc 주식(SI)의 최신 뉴스
Top Brass Pile Into Shoulder Innovations Stock in a Bold Insider Buying Spree - TipRanks
Shoulder Innovations (NYSE:SI) CEO Robert Joseph Ball Acquires 2,200 Shares - MarketBeat
Insider Buying: Shoulder Innovations (NYSE:SI) CFO Acquires 2,000 Shares of Stock - MarketBeat
Shoulder Innovations (NYSE:SI) Director Purchases $14,840.00 in Stock - MarketBeat
Buchholz Richard buys shoulder innovations (SI) stock worth $14,840 - Investing.com
Shoulder Innovations (SI) CFO exercises options and buys additional shares - Stock Titan
Ball Robert Joseph, CEO, buys Shoulder Innovations (SI) shares worth $33,392 - Investing.com
Director exercises 45,606 options in Shoulder Innovations (SI) - Stock Titan
Director buys 1,000 Shoulder Innovations (SI) shares at $14.84 - Stock Titan
Shoulder Innovations (SI) CEO adds 2,200 shares in open-market buy - Stock Titan
SI SEC FilingsShoulder Innovations, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Shoulder Innovations, Inc. (NYSE:SI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Shoulder Innovations (SI) Stock Forecast and Price Target 2026 $SI - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI) - The Globe and Mail
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evotec AG (EVO), Shoulder Innovations, Inc. (SI) and Bausch + Lomb Corporation (BLCO) - The Globe and Mail
Shoulder Innovations (SI) Revenue Growth Reinforces Bullish Narratives Despite Continued EPS Loss - simplywall.st
Shoulder Innovations, Inc. – Transforming Shoulder Surgical Care with Advanced Implant Systems and AI-Enabled Technologies (2025 Company Overview) - Minichart
Shoulder Innovations (NYSE:SI) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
BTIG Research Issues Positive Forecast for Shoulder Innovations (NYSE:SI) Stock Price - MarketBeat
BTIG raises Shoulder Innovations stock price target on revenue beat By Investing.com - Investing.com Nigeria
Shoulder Innovations revenue up 65% to USD 14.4M in Q4 2025 - Medical Buyer
Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results - The Malaysian Reserve
BTIG raises Shoulder Innovations stock price target on revenue beat - Investing.com South Africa
Earnings call transcript: Shoulder Innovations reports strong Q4 2025 growth By Investing.com - Investing.com Canada
Shoulder Innovations Q4 Earnings Call Highlights - MarketBeat
Shoulder Innovations Reports Fourth Quarter And Full Year 2025 Financial Results - TradingView
Shoulder Innovations Inc reports results for the quarter ended December 31Earnings Summary - TradingView
SI: Exceptional 2025 growth with robust 2026 outlook, fueled by innovation and ASC momentum - TradingView
Earnings call transcript: Shoulder Innovations reports strong Q4 2025 growth - Investing.com
Shoulder Innovations Reports Transformational 2025 Growth and Guidance - TipRanks
AAR to announce third quarter fiscal year 2026 results on March 24, 2026 - Weekly Voice
SHOULDER INNOVATIONS ($SI) Releases Q4 2025 Earnings - Quiver Quantitative
SI: Innovative implants and AI-driven planning fuel rapid growth and high margins in shoulder arthroplasty - TradingView
SI: Q4 revenue up 65% year-over-year; 2026 guidance targets 31–37% growth - TradingView
Shoulder Innovations (NYSE: SI) 2025 revenue jumps 50% as losses widen - Stock Titan
Shoulder Innovations, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
Shoulder Innovations Q4 2025 Earnings Call Transcript - MarketBeat
Shoulder Innovations Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Director Andrew Hykes files Form 3 at Shoulder Innovations (SI) - Stock Titan
Shoulder Innovations, Inc. (NYSE:SI) Short Interest Update - MarketBeat
SI: AI-driven planning, innovative implants, and robotics fuel rapid growth in shoulder arthroplasty - TradingView
Shoulder Innovations adds Drew Hykes to board of directors By Investing.com - Investing.com South Africa
Shoulder Innovations adds Drew Hykes to board of directors - Investing.com
Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Boar - GuruFocus
Shoulder Innovations Adds Medtech Veteran Drew Hykes to Board - TipRanks
Medtech leader Drew Hykes joins Shoulder Innovations (NYSE: SI) board after Pardo exit - Stock Titan
Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors - Nasdaq
Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Senseonics Holdings (SENS) and Novo Nordisk (NVO) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Charles River Labs (CRL) and Warby Parker (WRBY) - The Globe and Mail
Shoulder Innovations, Inc. (NYSE:SI) Receives $20.60 Consensus Price Target from Brokerages - Defense World
Shoulder Innovations to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference - The Malaysian Reserve
Shoulder Innovations Inc (SI) 재무 분석
Shoulder Innovations Inc (SI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):